Further to the announcement released on 17 August 2020 (RNS No: 2159W) relating to the appointment of Paul Watts as Chief Customer Officer, the Board of RDT is pleased to confirm that all the usual regulatory checks have been completed and that Paul will join the Board of the Company with immediate effect.
Gaming Realms announces that Simon Collins is stepping down from his role as a Non-Executive Director of Gaming Realms. This change takes effect from today.
Further to the announcement dated 2 September 2019, the Board confirms that its Chief Executive Officer Eddie Buxton will resign from the Board today, 4 October 2019. As previously stated, he will be leaving the Company on 31 December 2019. The Board is keen to record its thanks to Eddie for his leadership of the business for over ten years and to wish him well for the future.
Frontier announced on 30 July 2019 that it had reached agreement with Science Group plc (“Science Group”) on the future composition of the Board, reflecting the recent changes in the shareholder structure of the Company.
SimiGon, Ltd. (LSE: SIM), a global leader in modelling, simulation and training solutions, announces that after more than 14 years as Non-Executive Chairman of SimiGon, Alistair Rae has today stepped down from the Board of Directors.
Open Orphan, a European-focussed, rare and orphan drug consulting services platform, is pleased to announce the appointment to the board of David Kelly as an Independent Non-Executive Director.
CentralNic Group PLC (AIM: CNIC), the global internet platform that derives revenue from the subscription sales of internet domain names, is pleased to announce that Alexander Oskar Siffrin (‘Alex’), the Company’s Chief Operating Officer (COO) has been appointed to the Company’s board with immediate effect.
The boards of Frontier and Science Group PLC (“Science Group”) announce that they have reached agreement on the future composition of the Frontier Board to reflect recent changes in the shareholder structure of Frontier.
LONDON, Silence Therapeutics, PLC (LON: SLN) (“Silence” or “the Company”) a leader in the discovery, development and delivery of novel RNA therapeutics for the treatment of serious diseases, is pleased to announce that further to the announcements on 18 July 2019 detailing the Company’s collaboration with and equity investment by Mallinckrodt plc (NYSE: MNK), Steven Romano, MD, has today joined the Board of Silence as a Non-Executive Director.
Ascent Resources plc (AIM: AST), an independent oil and gas exploration and production company, operating the Petišovci Tight Gas Project in Slovenia, is pleased to provide the following corporate update incorporating board changes, future strategic direction, permitting and cost reduction measures.